Extension Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis, effective as of January 1, 2023

EX-10.1 2 tm2233702d1_ex10-1.htm EXHIBIT 10.1

Exhibit 10.1

CYCLACEL PHARMACEUTICALS, INC.

200 Connell Drive, Suite 1500

Berkeley Heights, NJ 07922

December 28, 2022

Mr. Spiro Rombotis

c/o Cyclacel Pharmaceuticals, Inc.

200 Connell Drive, Suite 1500

Berkeley Heights, NJ 07922

Dear Mr. Rombotis:

Reference is made to the agreement between us (the “Agreement”) made as of January 1, 2021. This will confirm our agreement to extend the Agreement through the period ended June 1, 2023, effective as of January 1, 2023. Please confirm your agreement to the foregoing by signing below in the space provided.

	Sincerely,

	CYCLACEL PHARMACEUTICALS, INC.

	By:	/s/ Paul McBarron
	Name:	Paul McBarron
	Title:	EVP, Finance & COO

ACKNOWLEDGED AND AGREED:

/s/ Spiro Rombotis
Spiro Rombotis